Superparamagnetic graphene oxide/magnetite nanocomposite delivery system for doxorubicin-induced distinguished tumor cell cycle arrest and apoptosis
Source abstract
Abstract
By taking the advantage of supraparamagnetic graphene oxide (GO/Fe3O4) hybrid nanocomposite, as a drug delivery system with high thermal conductivity without altering its anti-tumor efficacy, this study aimed to investigate the behavior of doxorubicin (DOX) loaded onto GO/Fe3O4 as passive (GO/Fe3O4/DOX) or with folic acid (FA) as active (GO/Fe3O4/FA/DOX) hybrid form before and after external exposure to infrared radiation (IR), as a hyperthermia source. In addition to investigation of its anti-tumor actions and the associated cardiotoxicity effect, the conjugates were characterized by using TEM, FT-IR, and TGA analysis. Ehrlich ascites carcinoma (EAC) breast cancer cell line was used to assess the anti-tumor effects of these conjugates in vivo. The results confirmed the nanosize of conjugates, which showed high loading capacity surface area for DOX reaching up to 90%. Although the conjugates showed strong anti-tumor effects similar to those of DOX, they expressed different impacts on cell cycle and apoptosis of EAC cells. Additionally, when the conjugates were stimulated with IR, the level of creatine kinase-MB (CK-MB) as a cardiac biomarker was close to normal level. In conclusion, active (GO/Fe3O4/FA/DOX) hybrid form in combination with brief hyperthermia induces anti-tumor effect with less cardiotoxicity. Further studies are needed to optimize the beneficial effects of this kind of hyperthermia and to understand the underlying mechanisms.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Akhavan O, Ghaderi E, Alireza A (2012) Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33:8017–802510.1016/j.biomaterials.2012.07.040 ↗
2. Bhatia S (2016) Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications in natural polymer drug delivery systems: nanoparticles, plants, and algae. Springer International Publishing, Switzerland, pp 33–93. https://doi.org/10.1007/978-3-319-41129-3_210.1007/978-3-319-41129-3_2 ↗
3. Chen Y et al (2014) Multifunctional graphene oxide-based triple stimuli-responsive. Nanotheranostics Adv Funct Mater 24:4386–439610.1002/adfm.201400221 ↗
4. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 121:159–17610.1016/j.clim.2006.06.006 ↗
5. Dickerson EB et al (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269:57–66. https://doi.org/10.1016/j.canlet.2008.04.02610.1016/j.canlet.2008.04.026 ↗
6. Feng L, Li K, Shi X, Gao M, Liu J, Liu Z (2014) Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance. Adv Healthcare Mater 3:1261–127110.1002/adhm.201300549 ↗
7. Feng L, Liu Z (2011) Graphene in biomedicine: opportunities and challenges. Nanomedicine (Lond) 6:317–324. https://doi.org/10.2217/nnm.10.15810.2217/nnm.10.158 ↗
8. Fong YT, Chen CH, Chen JP (2017) Intratumoral delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer. Therapy Nanomaterials (Basel) 7:388. https://doi.org/10.3390/nano711038810.3390/nano7110388 ↗
9. Gerard EI, Karen VH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–34810.1038/35077213 ↗
10. Gong P et al (2018) Fluorinated graphene as an anticancer nanocarrier: an experimental and DFT study. Journal of Materials Chemistry B 6:2769–277710.1039/C8TB00102B ↗
11. Hervault A, Thanh NT (2014) Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale 6:11553–11573. https://doi.org/10.1039/c4nr03482a10.1039/c4nr03482a ↗
12. Iversen NK et al (2013) Superparamagnetic iron oxide polyacrylic acid coated gamma-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol Appl Pharmacol 266:276–288. https://doi.org/10.1016/j.taap.2012.10.01410.1016/j.taap.2012.10.014 ↗
13. Khan M et al (2016) Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer. Int J Nanomedicine 11:873–883. https://doi.org/10.2147/IJN.S10090310.2147/IJN.S100903 ↗
14. Kim KJ, Joe V, Kim MK, Lee SJ, Ryu YH, Cho DW, Rhie JW (2015) Silica nanoparticles increase human adipose tissue-derived stem cell proliferation through ERK1/2 activation. Int J Nanomedicine 10:2261–227210.2147/IJN.S71925 ↗
15. Kong LJS (2007) Heat shock protein 70 inhibits the nuclear import of apoptosis inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis. FEBS Lett 58:109–117
16. Kuhl NMJKLR (2000) Heat shock-induced arrests in different cell cycle phases of rat C6-glioma cells are attenuated in heat shock-primed thermo tolerant cells. Cell Prolif 33:147–16610.1046/j.1365-2184.2000.00175.x ↗
17. Licciardi M, Giammona G, Du J, Armes SP, Tang Y, Lewis AL (2006) New folate-functionalised biocompatible block copolymer micelles as potential anti-cancer drug delivery systems. Polymer 47:2946–2955. https://doi.org/10.1016/j.polymer.2006.03.01410.1016/j.polymer.2006.03.014 ↗
18. Linares J, Matesanz MC, Feito MJ, Salavagione HJ, Martinez G, Gomez-Fatou M, Portoles MT (2016) Influence of the covalent immobilization of graphene oxide in poly(vinyl alcohol) on human osteoblast response. Colloids Surf B Biointerfaces 138:50–59. https://doi.org/10.1016/j.colsurfb.2015.11.03510.1016/j.colsurfb.2015.11.035 ↗
19. Ma X et al (2012a) A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Research 5:199–212. https://doi.org/10.1007/s12274-012-0200-y10.1007/s12274-012-0200-y ↗
20. Ma XX, Tao HQ, Yang K, Feng LZ, Cheng L, Shi XZ (2012b) A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 5:199–21210.1007/s12274-012-0200-y ↗
21. Marcano DC et al (2010) Improved synthesis of graphene oxide. ACS Nano 4:4806–4814. https://doi.org/10.1021/nn100636810.1021/nn1006368 ↗
22. Mirhosseini MM, Rahmati M, Zargarian SS, Khordad R (2017) Molecular dynamics simulation of functionalized graphene surface for high efficient loading of doxorubicin. J Mol Struct 1141:441–450. https://doi.org/10.1016/j.molstruc.2017.04.00710.1016/j.molstruc.2017.04.007 ↗
23. Muazim K, Hussain Z (2017) Graphene oxide—a platform towards theranostics. Mater Sci Eng C 76:1274–1288. https://doi.org/10.1016/j.msec.2017.02.12110.1016/j.msec.2017.02.121 ↗
24. Offelt SB, Visser KE (2015) Immune-mediated mechanisms influencing the efficacy of anticancer therapies. Trends Immunol 36:198–216. https://doi.org/10.1016/j.it.2015.02.00610.1016/j.it.2015.02.006 ↗
25. Patel P, Kansara K, Senapati VA, Shanker R, Dhawan A, Kumar A (2016) Cell cycle dependent cellular uptake of zinc oxide nanoparticles in human epidermal cells. Mutagenesis 31:481–49010.1093/mutage/gew014 ↗
26. Qin XC, Guo ZY, Liu ZM, Zhang W, Wan MM, Yang BW (2013) Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B 120:156–162. https://doi.org/10.1016/j.jphotobiol.2012.12.00510.1016/j.jphotobiol.2012.12.005 ↗
27. Sahu A, Choi WI, Lee JH, Tae G (2013) Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 34:6239–6248. https://doi.org/10.1016/j.biomaterials.2013.04.06610.1016/j.biomaterials.2013.04.066 ↗
28. Sanchez VC, Jachak A, Hurt RH, Kane AB (2012) Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 25:15–34. https://doi.org/10.1021/tx200339h10.1021/tx200339h ↗
29. Shim G, Kim JY, Han J, Chung SW, Lee S, Byun Y, Oh YK (2014) Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs. J Control Release 189:80–8910.1016/j.jconrel.2014.06.026 ↗
30. Siriviriyanun A, Popova M, Imae T, Kiew LV, Looi CY, Wong WF (2015) Preparation of graphene oxide/dendrimer hybrid carriers for delivery of doxorubicin. Chem Eng J 281:771–781. https://doi.org/10.1016/j.cej.2015.07.02410.1016/j.cej.2015.07.024 ↗
31. Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, D’Angelo J, Cattel L, Couvreur P (2000) Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89:1452–1464. https://doi.org/10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p ↗
32. Su J, Chen F, Cryns V, Messersmith P (2011) Catechol polymers for pH-responsive targeted drug delivery to cancer cells. J Am Chem Soc 133:11850–1185310.1021/ja203077x ↗
33. Sugahara T, van der Zee J, Kampinga HH, Vujaskovic Z, Kondo M, Ohnishi T, Li G, Park HJ, Leeper DB, Ostapenko V, Repasky EA, Watanabe M, Song CW (2008) Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15-18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report. Int J Hyperthermia 24:123–140. https://doi.org/10.1080/0265673070188367510.1080/02656730701883675 ↗
34. Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330–352. https://doi.org/10.1016/j.pcad.2006.10.00210.1016/j.pcad.2006.10.002 ↗
35. Vander JZ (2002) Heating the patient: a promising approach? Ann Oncol 13:1173–118410.1093/annonc/mdf280 ↗
36. Wu J, Li Z, Li Y, Pettitt A, Zhou F (2018) Photothermal effects of reduced graphene oxide on pancreatic cancer. Technol Cancer Res Treat 17:1533034618768637. https://doi.org/10.1177/153303461876863710.1177/1533034618768637 ↗
37. Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y (2014) Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells. International Journal of Nanomedicine 9:1413–1421. https://doi.org/10.2147/IJN.S5794610.2147/IJN.S57946 ↗
38. Wu S, Zhao X, Li Y, du Q, Sun J, Wang Y, Wang X, Xia Y, Wang Z, Xia L (2013) Adsorption properties of doxorubicin hydrochloride onto graphene oxide: equilibrium. Kinetic and Thermodynamic Studies Materials (Basel) 6:2026–2042. https://doi.org/10.3390/ma605202610.3390/ma6052026 ↗
39. Yang K et al (2012) Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater 24:1868–1872. https://doi.org/10.1002/adma.20110496410.1002/adma.201104964 ↗
40. Zhao GX, Li JX, Wang XK (2011) Kinetic and thermodynamic study of 1-naphthol adsorption from aqueous solution to sulfonated graphene nanosheets. Chem Eng J 173:185–19010.1016/j.cej.2011.07.072 ↗
41. Zhao L, Zhang B (2017) Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep 7:44735. https://doi.org/10.1038/srep4473510.1038/srep44735 ↗
42. Zhou T, Zhou X, Xing D (2014) Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials 35:4185–4194. https://doi.org/10.1016/j.biomaterials.2014.01.04410.1016/j.biomaterials.2014.01.044 ↗